OncoNano Medicine Appoints Dr. Kartik Krishnan as Chief Executive Officer and Dr. Melissa Paoloni as Executive Vice President and Chief Operating Officer
OncoNano Medicine, Inc. announces the appointment of Dr. Kartik Krishnan, MD, PhD to Chief Executive Officer (CEO) and member of the Board of Directors, succeeding Martin Driscoll
Company Information
Company
OncoNano Medicine
Location
3060 Pegasus Park Drive
Dallas, Texas, United States
About
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.
Fundz sees it the moment OncoNano Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DallasBiotechnologyHealth CareMedicalTherapeutics